Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00848237 · ClinicalTrials.gov registry record · NA
HALO Patient Registry: Ablation of Barrett's Esophagus
A NA study of Barrett Esophagus, sponsored by Medtronic - MITG.
- Completed
- Registry status
- NA
- Development phase
- 5,521
- Enrollment target
- 1
- Study location
NCT00848237 is a NA study of Barrett Esophagus that has completed, run by Medtronic - MITG. The registered enrollment target is 5,521 participants, above the 3,393-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (63% higher). The trial reports 1 study location across 1 state.
The verdict
NCT00848237, a NA study of Barrett Esophagus, has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- NA
- Development phase
- 5,521 participants
- Enrollment target
- 1
- Study location
Study Summary
The HALO Patient Registry is a prospective/retrospective, multi-center patient registry. It provides a framework for treatment and follow-up of patients with Barrett's esophagus (non-dysplastic IM, LGD and HGD). The primary objective is to provide a tool for participating physician investigators to collect outcomes data related to the use of the HALO Ablation Systems.
Conditions Studied
Interventions
- DEVICE Radiofrequency Ablation (HALO Ablation Systems)
Study Locations (1)
California
- Gastrointestinal Associates and sites across the US - Knoxville and Other US Cities
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,521 participants |
| Start Date | 2007-07 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00848237
The ClinicalTrials.gov registry entry for NCT00848237 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5,521 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,393-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (63% higher). The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which Radiofrequency Ablation (HALO Ablation Systems) is the first listed.
NCT00848237 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00848237 about?
NCT00848237 is a clinical study titled "HALO Patient Registry: Ablation of Barrett's Esophagus". The HALO Patient Registry is a prospective/retrospective, multi-center patient registry. It provides a framework for treatment and follow-up of patients with Barrett's esophagus (non-dysplastic IM, LGD and HGD). The primary objective is to provide a tool for participating physician investigators to ...
What is the current status of trial NCT00848237?
This trial is currently completed. It is a NA study. The enrollment target is 5,521 participants. The study started on 2007-07. Estimated completion is 2014-07.
What conditions does trial NCT00848237 study?
This clinical trial studies the following conditions: Barrett Esophagus.
What interventions are being tested in trial NCT00848237?
The interventions under investigation include: Radiofrequency Ablation (HALO Ablation Systems) (DEVICE).
Who is sponsoring clinical trial NCT00848237?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00848237 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
RECRUITING · NA
-
Pilot Study for OCT Guided In Vivo Laser Capture Microdissection for Assessing the Prognosis of Barrett's Esophagus
RECRUITING · NA
-
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.